Table of contents

Articles

• NEW ASPECTS REGARDING NEOADJUVANT RADIOCHEMOTHERAPY IN LOCALLY ADVANCED NONINFLAMMATORY BREAST CANCER AND PREDICTIVE FACTORS FOR A PATHOLOGIC COMPLETE REMISSION: IGCS-0016 Breast Cancer (1 May, 2015)

  C. Matuschek, E. Boelke, W. Budach, V. Speer, H. Bojar, W. Audretsch, K. Nestle
• MANAGEMENT OF MICROMETASTASIS FOUND ON SENTINEL LYMPH NODE BIOPSY USING OSNA IN PATIENTS DIAGNOSED WITH EARLY BREAST CANCER: IGCS-0021 Breast Cancer (1 May, 2015)

  M. Chopra, F. Alam, Y. Mir, Mc S. Pherson, L. Richards, H. Wong
• SERIAL RESECTIONS IN METASTATIC BREAST CANCER: IGCS-0035 Breast Cancer (1 May, 2015)

  N. Bacabasa, I. Dinu, A. Martiniuc, L. David
• COSMETIC OUTCOME ASSESSMENT AFTER NEOADJUVANT RADIOCHEMOTHERAPY IN BREAST CANCER PATIENTS: IGCS-0036 Breast Cancer (1 May, 2015)

  E. Boelke, W. Budach, V. Speer, S. Wollandt, P. A. Gerber, W. Audretsch, Nestle C. Krämling, C. Matuschek
• NEOADYUVANT HORMONOTHERAPY IN LOCALLY ADVANCED BREAST CANCER, POSMENOPAUSIC WOMEN WITH HORMONAL RECEPTORS POSITIVE: IGCS-0049 Breast Cancer (1 May, 2015)

  N. Arturo, A. Novoa
• TREATMENT AND OUTCOME OF STAGE I A1 SQUAMOUS CARCINOMA OF THE CERVIX: A CLINICOPATHOLOGIC STUDY OF 346 CASES: IGCS-0011 Cervical Cancer (1 May, 2015)

  M. R. Liang, S. Y. Zeng, W. Jiang, L. Li, M. L. Zhong, O. P. Huang
• APOPTOTIC PATHWAY OF ZINC ON CERVICAL CANCER CELL LINE: IGCS-0020 Cervical Cancer (1 May, 2015)

  S. N. Bae, E. Y. Ki, H. K. Chang, Y. K. Lee, K. H. Lee
• THE VALUE OF CYTOKERATIN 19 AND HUMAN PAPILLOMA VIRUS DNA AS MICROMETASTASIS MARKERS IN CERVICAL CANCER PATIENTS WITH INTERMEDIATE RISK FACTORS: IGCS-0022 Cervical Cancer (1 May, 2015)

  Dae H. Gy, M. J. Kim, Y. H. Lee, G. O. Chong, Y. S. Lee, Y. L. Cho, J. Y. Park
• CLINICAL OUTCOMES AND HEALTH-RELATED QUALITY OF LIFE OF PATIENTS WHO HAD UNDERGONE TOTAL LAPAROSCOPIC VERSUS TOTAL ROBOTIC RADICAL HYSTERECTOMY FOR CERVICAL CARCINOMA: IGCS-0024 Cervical Cancer (1 May, 2015)

  Dae H. Gy, J. Y. Kim, Y. H. Lee, G. O. Chong, Y. S. Lee, Y. L. Cho
• ATYPICAL HEPATECTOMY FOR LIVER METASTASES FROM CERVICAL CANCER: IGCS-0029 Cervical Cancer (1 May, 2015)

  N. Bacabasa, I. Balescu, C. Stoica
• HYPOXIA AND BIOMARKERS EXPRESSION IN CERVICAL CANCER (CC) AND HIGH GRADE SQUAMOUS INTRAEPITHELIAL LESIONS (HSIL): IGCS-0037 Cervical Cancer (1 May, 2015)

  M. A. Ostojich, S. Gianni, L. Marino, E. Lupo, D. De Dios, N. Zeff, L. Lay, F. Damiani, A. Sanchez, L. Gimenez, M. A. Jasnis
• ACCURACY OF 18 F-FDG PET/CT FOR THE DETECTION OF PARA-AORTIC LYMPH NODE METASTASIS IN PATIENTS WITH EARLY BULKY AND LOCALLY ADVANCED UTERINE CERVICAL CARCINOMA.FIRST NATIONAL EXPERIENCE: IGCS-0046 Cervical Cancer (1 May, 2015)

  Acuña D. Aravena, R. Pruzzo, N. Barrena, H. Amaral, P. Torres, Y. McConell, S. Ramírez
• SURVIVAL OF CERVICAL CANCER TYPE SQUAMOUS AND ADENOCARCINOMA IN PATIENTS FROM THE NATIONAL CANCER INSTITUTE, BETWEEN 2009–2013, CHILE: IGCS-0050 Cervical Cancer (1 May, 2015)

  P. Gayan, M. Villalobos, C. Wendling, C. Sierra, O. Valencia, M. Carcamo, S. Prado, A. Selman, J. Garrido
• UTERINE CERVICAL CANCER RECURRENCE PATTERN IN HIGUERAS HOSPITAL,TALCAHUANO - CHILE,BETWEEN 2003 AND 2014: IGCS-0052 Cervical Cancer (1 May, 2015)

  A. Vigueras, M. Hinostroza, J. Araneda, A. Moraga
• CYTOHISTOLOGICAL CORRELATION IN CPU HIGUERAS HOSPITAL, TALCAHUANO - CHILE, BETWEEN 2003 AND 2014.: IGCS-0054 Cervical Cancer (1 May, 2015)

  E. Vivaldi, A. Vigueras, V. Ruf
• BIOMARKER ASSESSMENT IN CERVICAL UTERINE CANCER: IGCS-0055 Cervical Cancer (1 May, 2015)

  R. Medina-Berlanga, S. Blancas, L. Santos
• AVALIATION OF RESIDUAL DISEASE IN HYSTERECTOMY SPECIMENS AFTER CONIZATION IN WOMEN TREATED FOR SQUAMOUS MICROINVASIVE CARCINOMA OF THE UTERINE CERVIX: IGCS-0064 Cervical Cancer (1 May, 2015)

  C. A. Hartman, M. S.C. Gurgel, J. C. Teixeira, S. M. Figueiredo, J. Y. Yoneda, O. F. Rangel, Braganca J. Bastos
• SURVIVAL IN CERVICAL CANCER PATIENTS TREATED BY MINIMALLY INVASIVE SURGERY: IGCS-0066 Cervical Cancer (1 May, 2015)

  S. Pessini, G. P.G. Silveira, M. P. Salcedo, M. C.B. Anselmi
• DISEASE RECURRENCE AFTER LOOP TREATMENT FOR HIGH GRADE CERVICAL INTRAEPITHELIAL NEOPLASIA: IGCS-0070 Cervical Cancer (1 May, 2015)

  J. Y. Yoneda, L. C. Zeferino, M. Marangoni, M. P. Funari, T. Sapper, C. A. Hartman, O. F. Rangel, J. F. Braganca
• CERVICAL CANCER AND PREGNANCY: THREE CASES DURING 2014 IN CARLOS VAN BUREN HOSPITAL, VALPARAISO-CHILE: IGCS-0072 Cervical Cancer (1 May, 2015)

  H. Riesle, S. Parry, C. Bazan
• POSITIVE MARGINS IN COLD KNIFE CONE: PREVALENCE AND RESIDUAL LESIONS: IGCS-0073 Cervical Cancer (1 May, 2015)

  R. V. Almeida, M. P. Salcedo, D. Gottlieb, D. P. Todeschini, S. A. Pessini
• LAPAROSCOPIC RADICAL TRACHELECTOMY: TECHNIQUE, FEASIBILITY AND OUTCOMES. EXPERIENCE HOSPITAL ITALIANO BUENOS AIRES, ARGENTINA: IGCS-0075 Cervical Cancer (1 May, 2015)

  J. M. Saadi, M. Perrotta, M. Giavedoni, G. Salvo, R. Orti
• VAGINAL RADICAL TRACHELECTOMY. A 10 YEARS EXPERIENCE OF 3 CENTERS IN CHILE: IGCS-0076 Cervical Cancer (1 May, 2015)

  Lehuede A. Massa, Saez N. Orellana, Cuello M. Fredes, Garcia K. Astudillo, Majerson D. Burztyn, Paredes C. Martinez, Hinostroza M. Scheel, Young D. Hwang, Brañes J. Yunusic
• EVALUATION OF CONE DEPTH TO ACHIEVE NEGATIVE MARGINS AFTER ELECTROSURGICAL TREATMENT FOR HIGH GRADE CERVICAL INTRAEPITHELIAL NEOPLASIA: IGCS-0078 Cervical Cancer (1 May, 2015)

  J. Y. Yoneda, L. C. Zeferino, M. P. Funari, M. Marangoni, T. Sapper, E. C. Candido, J. F. Braganca
• LAPAROSCOPIC POSTERIOR EXENTERATION IN CERVICAL CANCER: INITIAL EXPERIENCE AT HOSPITAL ITALIANO DE BUENOS AIRES: IGCS-0085 Cervical Cancer (1 May, 2015)

  D. Odetto, J. Saadi, G. Saraniti, F. Noll, G. Salvo, M. Perrotta
• TREATMENT OUTCOMES OF PATIENTS WITH EARLY STAGE CERVICAL CANCER TREATED WITH LAPAROTOMY COMPARED TO ROBOTICALLY ASSISTED LAPAROSCOPIC APPROACH: IGCS-0089 Cervical Cancer (1 May, 2015)

  K. Seader, S. Rao, Y. Hemida, E. Hashemi, M. Pitter, P. Anderson, G. Sommers
• LAPAROSCOPIC PARAAORTIC INFRARENAL LYMPHADENECTOMY: ANATOMICAL ANOMALIES FOUND IN OUR SERIES OF CASES AT THE GYNECOLOGIC ONCOLOGY SECTION, DEPARTMENT OF GYNECOLOGY, HOSPITAL ITALIANO DE BUENOS AIRES: IGCS-0090 Cervical Cancer (1 May, 2015)

  F. Noll, J. Saadi, D. Odetto, G. Saraniti, M. Perrotta
• O&G RESIDENTS IN BRAZIL WOULD CONSIDER GYNECOLOGIC ONCOLOGY AS A SUBSPECIALTY IF IT WERE OFFICIALLY RECOGNIZED AND DON'T FEEL READY TO PERFORM RADICAL HYSTERECTOMIES: IGCS-0091 Cervical Cancer (1 May, 2015)

  L. Campbell, W. Primo, R. Miziara, P. Brito, L. Casulari
• CLINICAL ADVANTAGES OF NERVE-SPARING RADICAL HYSTERECTOMY OF CERVICAL CANCER: IGCS-0096 Cervical Cancer (1 May, 2015)

  S. Parry, H. Riesle, C. Bazan
• DETECTION OF E6-E7 MRNA OF HIGH RISK HUMAN PAPILLOMAVIRUS IN NEGATIVE LYMPH NODES IN PATIENTS WITH CERVICAL CANCER: A POSSIBLE EARLY BIOMARKER OF SUBCLINICAL METASTASIS: IGCS-0104 Cervical Cancer (1 May, 2015)

  J. A. Basiletti, M. A. Picconi, S. Vornetti, A. soderini, N. Cúneo, G. Etcheverry, L. V. Alonio
• THE ABDOMINAL RADICAL TRACHELECTOMY SPARING THE UTERINE ARTERIES (A.R.T.- S.U.A) & THE PELVIC AUTONOMIC PLEXUS (P.P.A.P.) IN CERVICAL CANCER (CC): ONCOLOGICAL & FERTILITY OUTCOMES OF THIS NOVEL SURGICAL TECHNIQUE: IGCS-0105 Cervical Cancer (1 May, 2015)

  A. Soderini, A. Aragona, E. Bonavía, Mollar P. Vigh, M. V. Minaudo, E. Petrocino, L. Di Biase, N. Cuneo
• GESTATIONAL TROPHOBLASTIC DISEASE: INCREASE OF INCIDENCE IN CARLOS VAN BUREN HOSPITAL, VALPARAISO - CHILE: IGCS-0074 Gestational Trophoblastic Neoplasia (1 May, 2015)

  C. Bazan, S. Parry, H. Riesle
• MOLECULAR CHARACTERIZATION OF GESTATIONAL TROPHOBLASTIC DISEASE: IGCS-0097 Gestational Trophoblastic Neoplasia (1 May, 2015)

  I. Castillo, J. Lopez, J. E. Leiva, C. Paredes, R. Correa
• ROLE OF INDOCYANINE GREEN (ICG) IN SENTINEL NODE MAPPING IN GYNECOLOGIC CANCER: A TIME FOR A NEW STANDARD OF CARE?: IGCS-0083 Imaging / Staging (1 May, 2015)

  M. C. Darin, Rodriguez N. Gómez-Hidalgo, P. Escobar, M. Frumovitz, P. T. Ramirez
• LAPAROSCOPIC TREATMENT FOR ISOLATED PARA-AORTIC LYMPH NODE RECURRENCE: IGCS-0086 Imaging / Staging (1 May, 2015)

  G. Saraniti, M. T. Labanca, J. M. Saadi, R. Orti, M. Perrotta
• ASSESSMENT OF POSTOPERATIVE MORBIDITY RISK AFTER HYSTERECTOMY USING THE SURGICAL APGAR SCORE: IGCS-0041 05. Nursing, Symptom Management, Palliation (1 May, 2015)

  T. Shemshedini, T. S. Pradhan, S. Labrecque, F. Moy, S. S. Tedjarati, T. L. Pua
• THE RELATIONSHIP BETWEEN SELF-EFFICACY AND ADHERENCE TO PAP TEST IN A GROUP OF CHILEAN WOMEN: IGCS-0051 Nursing, Symptom Management, Palliation (1 May, 2015)

  M. T. Urrutia
• MOST QUALITY OF LIFE QUESTIONNAIRES USED IN PEER-REVIEWED CERVICAL CANCER SURVIVALS SURVEYS ARE NOT DISEASE-SPECIFIC INSTRUMENTS AND HAVE NOT BEEN PREVIOUSLY VALIDATED: IGCS-0094 Nursing, Symptom Management, Palliation (1 May, 2015)

  L. M. Campbell, W. Q. Primo, R. F. Miziara, P. V. Brito, L. A. Casulari
• LIFETIME RISK OF OVARIAN CANCER BASED ON ENDOMETRIOSIS AND OTHER RISK FACTORS: IGCS-0014 06. Ovarian Cancer (1 May, 2015)

  R. Ness, C. Pearce, D. Stram, A. Berchuck, M. Pike, P. Pharoah
• DOES TALC EXPOSURE CAUSE OVARIAN CANCER?: IGCS-0015 Ovarian Cancer (1 May, 2015)

  R. Ness
• SURGICAL STAGING OF OVARIAN CANCER (I FIGO STAGE): IGCS-0018 Ovarian Cancer (1 May, 2015)

  E. Ismail, Y. Kornovski
• ADVANCED STAGE OF EPITHELIAL OVARIAN CANCER (II-IV FIGO STAGE). THE ROLE OF LYMPH NODE DISSECTION: IGCS-0019 Ovarian Cancer (1 May, 2015)

  E. Ismail, Y. Kornovski
• NHE1 PROMOTE CELL PROLIFERATION IN OVARIAN CANCER: A ROLE OF HYPOXIA-INDUCIBLE FACTORS.: IGCS-0038 06. Ovarian Cancer (1 May, 2015)

  C. Sanhueza, J. Araos, L. Naranjo, T. Sáez, L. Silva, R. Salsoso, F. Pardo, A. Leiva, M. A. Cuello, M. Cornejo, M. A. Ramírez, L. Sobrevia
• DIFFERENTIALLY EXPRESSED MIRNAS AND THEIR SURVIVAL PREDICTION IN THE HIGH GRADE SEROUS AND CLEAR CELL OVARIAN CARCINOMA: IGCS-0043 06. Ovarian Cancer (1 May, 2015)

  S. Cui, G. Wang, X. Zhang, X. Wu, J. Zhao, X. Yu, Y. Ding
• FIBRIN SEALANT HEMOSTATIC PATCH CLINICAL EFFECTIVENESS EVALUATION IN ADVANCED OVARIAN CANCER PATIENTS UNDERWENT PELVIC LYMPHADENECTOMY: INSTITUTIONAL EXPERIENCE: IGCS-0062 06. Ovarian Cancer (1 May, 2015)

  D. R. Kaidarova, T. A. Yugai, T. T. Sadykova
• IFOSFAMIDUM AS PALLIATIVE TREATMENT FOR ADVANCED OVARIAN CANCER: IGCS-0063 06. Ovarian Cancer (1 May, 2015)

  S. Plate, Z. Zvirbule, S. Kasperova
• CAN WE IMPROVE DETECTION OF BORDERLINE OVARIAN TUMORS?: IGCS-0065 Ovarian Cancer (1 May, 2015)

  L. Singh, T. Pua, S. Tedjarati, C. Song, L. LeCompte, T. Pradhan
• BRAIN METASTASES FROM EPITHELIAL OVARIAN CANCER: CLINICOPATHOLOGICAL FINDINGS. A RETROSPECTIVE SINGLE INSTITUTION STUDY: IGCS-0067 06. Ovarian Cancer (1 May, 2015)

  R. Correa, C. Paredes, J. E. Leiva, R. Munoz, G. Avendano, I. Castillo
• CLINICAL MANAGEMENT OF BORDERLINE OVARIAN TUMORS IN DR SOTERO DEL RIO HOSPITAL: IGCS-0068 Ovarian Cancer (1 May, 2015)

  O. Puga, M. V. Perez, M. Farias, N. Saez, M. I. Barriga, K. Garcia, M. Saavedra, M. Fernandez, T. Rodriguez
• ADVANCED OVARIAN CANCER: A CHILEAN UNIVERSITY HOPITAL EXPERIENCE: IGCS-0077 Ovarian Cancer (1 May, 2015)

  Brañes J. Yunusic, Garcia K. Astudillo, Cuello M. Fredes, Majerson D. Burztyn, Barrena N. Medel, Young D. Hwang, Lehuede A. Massa, Saez N. Orellana, Perez M.V. Mendez
• SEROUS PSAMMOCARCINOMA OF THE OVARY AND PERITONEUM: LONG TERM RECURRENCE: IGCS-0080 Ovarian Cancer (1 May, 2015)

  G. Norese, A. Moreira, S. Alessandria, F. Gorosito, M. J. Lange, A. Bermudez
• LEPTIN PROMOTES A MORE AGGRESIVE BEHAVIOR OF OVARIAN CANCER CELLS: A POTENTIAL EXPLANATION FOR A WORSE PROGNOSIS IN OBESE OVARIAN CANCER PATIENTS: IGCS-0095 Ovarian Cancer (1 May, 2015)

  M. Cuello-Fredes, S. Kato, L. Abarzúa-Catalán, A. Delpiano, C. Trigo, K. García, C. Sanhueza, C. Ibañez, J. Brañes, E. Castellon, G. Owen
• MOLECULAR FINGERPRINTS OF MIXED ENDOMETRIOID AND SEROUS ADENOCARCINOMA OF THE ENDOMETRIUM: IGCS-0044 Uterine Cancer, including Sarcoma (1 May, 2015)

  P. Mhawech-Fauceglia
• UNDIFFERENTIATED ENDOMETRIAL CANCER, A DIFFERENT ENTITY WITH AN AGGRESSIVE BEHAVIOR: IGCS-0060 Uterine Cancer, including Sarcoma (1 May, 2015)

  W. Jimenez, J. Maxwell, D. Daya, M. Sur, L. Elit, L. Eiriksson, C. Reade, A. Lytwyn
• EARLY STAGE ENDOMETRIAL CANCER: LAPAROSCOPY VS LAPAROTOMY: IGCS-0081 Uterine Cancer, including Sarcoma (1 May, 2015)

  S. Alessandria, G. Norese, F. Gorosito, M. J. Lange, M. Nölting, A. Bermudez
• TWO CASE OF ATYPICAL ENDOMETRIAL HYPERPLASIA ASSOCIATED WITH “BIOIDENTICAL” HORMONE REPLACEMENT THERAPY: IGCS-0084 Uterine Cancer, including Sarcoma (1 May, 2015)

  Vrabic L. Dezman, M. Z. Gersak, K. Gersak
• THE SIGNIFICANCE OF PRE-OPERATIVE ENDOMETRIAL SAMPLING IN GRADE 1, LOW RISK ENDOMETRIAL CANCERS: IGCS-0088 Uterine Cancer, including Sarcoma (1 May, 2015)

  L. Singh, T. Pua, P. Khattar, L. Han, S. Tedjarati, T. Pradhan
• ROBOTIC SURGERY INCREASES PATIENT's ACCESS TO MINIMALLY INVASIVE SURGERY FOR HYSTERECTOMIES: IGCS-0098 Uterine Cancer, including Sarcoma (1 May, 2015)

  G. Forde, J. Chang, Z. A, K. Tewari, R. Bristow
• LASER VAPORIZATION IN VULVAR INTRAEPITHELIAL NEOPLASIA (VIN), VAGINAL INTRAEPITHELIAL NEOPLASIA (VAIN) AND CONDYLOMATA ACUMINATA: IGCS-0093 Vulvar and Vaginal Cancer (1 May, 2015)

  S. Ramirez, N. Barrena, Y. MC Conell, P. Torres, H. Leon, P. Jimenez, D. Acuna, M. Meneses
• PROGNOSTIC SIGNIFICANCE OF TUMOR SIZE IN SQUAMOUS CELL CARCINOMA OF THE VULVA: IGCS-0107 Vulvar and Vaginal Cancer (1 May, 2015)

  A. Soderini